Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘Novo Nordisk A/S (ADR) (NVO)’

Easiest Md/PhD Programs to Get Into

Here’s Our Take On The Global Blood Therapeutics Inc (GBT) Rumors

Global Blood Therapeutics Inc (NASDAQ:GBT) is spiking towards the end of the week on the suggestion that it might be an acquisition target for a big pharma......(read more)
abdomen, asian, batten, belly, big, body, boy, cellulite, check, child, children, concept, diabetes, diet, excess, fat, hand, health, healthy, heart, kid, kids, lung, male, obese, obesity, overweight, pressure, stethoscope, stomach, thick, unhealthy, weight, young

11 Fattest Countries in The World

The problem of obesity is a modern one, with large sections of the global population becoming overweight late in the 20th century and into the 21st, and......(read more)
court, courtroom, gavel, american, flag, legal, desk, background, legally, juror, guilt, chair, table, divorce, judgment, nobody, mallet, tool, brown, decisions, symbol,

Sanofi SA (ADR) (SNY) Files Suit Against Novo Nordisk A/S (ADR) (NVO) Over False Insulin Claims

Novo Nordisk A/S (ADR) (NYSE:NVO) has been sued by Sanofi SA (ADR) (NYSE:SNY) for making false claims. In the lawsuit filed in the United States, the......(read more)

10 Largest Hedge Funds in The World And Their Favorite Stock Picks

Which are the largest hedge funds in the world? Most investors see hedge fund size as an indication of investment success. It is partially true though......(read more)
people, person, lab, nuclear, hydrogen, concept, chemistry, technicians, researching, formula, chemists, biotechnology, researchers, discovery, weapon, samples,

US FDA Approves Sanofi SA (ADR) (SNY) Soliqua 100/33, Novo Nordisk A/S (ADR) (NVO) Xultophy 100/3.6

The US Food and Drug Administration (FDA) has recently approved the Soliqua 100/33 (insulin glargine and lixisenatide injection) of Sanofi SA (ADR) (NYSE......(read more)
strong, dollar, graph, money, arrow, cash, australian, australia, no, business, growth, blue, background, market, isolated, green, white, concept, 100, sign, success,

10 Most Successful Investors in the World

These 10 most successful investors in the world don’t have much in common aside from their obscene net worths. They come from different backgrounds,......(read more)
pharmacist, worker, shelves, business, counter, glasses, attractive, medical, competence, chemist, adult, clinic, drugstore, selling, female, consultation, medicine, coat

Novo Nordisk A/S (ADR) (NVO) Revisits New Strategy To Deal With U.S Payers

Novo Nordisk A/S (ADR) (NYSE:NVO) incoming President and CEO Lars Fruergaard Jørgensen is slated to start his leadership roles in the New Year. However......(read more)
background, modern, room,

5 Most Successful Quant Hedge Funds And Their Top Picks

The prominence of quantitative hedge funds in the alternative asset management space has increased exponentially since the turn of the century, with several......(read more)
Best Bumble Bios For Girls

Two Dividend Growth Stocks on My Radar

In the past few days, I have noticed that a couple of dividend growth stocks have been selling at lower prices than before. Those are companies that have......(read more)
pharmacist, worker, shelves, business, counter, glasses, attractive, medical, competence, chemist, adult, clinic, drugstore, selling, female, consultation, medicine, coat

Inside the FDA: Why Sanofi SA (ADR) (SNY) IGlarLixi Was Delayed But Novo Nordisk A/S (ADR) (NVO) IDegLira Wasn’t

Update: Several hours after the initial publication of this report on September 2, Novo Nordisk announced that the FDA has extended the regulatory......(read more)

VeriFone (PAY), Gilead (GILD) Among 5 Stocks That Hit 52-Week Lows Last Week

Although the S&P 500 and Dow Jones are near record highs, shares of five major companies crumbled to 52-week lows last week. In this article we’......(read more)
10 Pharmacist Shortage Countries in Need of Pharmacists in 2017

The Cryptic World of Oral Insulin, Novo Nordisk A/S (ADR) (NVO) vs Oramed Pharmaceuticals, Inc. (ORMP)

The problem with being at the top of one of the largest healthcare market niches in the world is extremely heightened expectations. The World Health Organization......(read more)
Healthcare Careers That Require a Master’s Degree

As Old Bestsellers Plateau, a Look at 4 Next Generation Diabetes Drugs

In part I of our comprehensive report on the type II diabetes market, we broke down the top 4 best selling diabetes drugs, their prospects and the companies......(read more)
medicine, diabetes, glycemia, health care,patient, insulin-deficient, middle, app, measurement, male, disease, hypoglycemia, level, technology, medicine, mobile, checking, body, home, smartphone, hyperglycemia, stripe, part, health, indoors, man, glucometer, healthcare, test, human, diabetic, aged, medical, unhealthy, concept, gadget, ill, diabetes, sick, glucose, care, problem, person, cell, sugar, control, application, phone, blood, hand, insulin

The Top Four Diabetes Best Sellers and One Oral Insulin Pill That May Threaten Them All

At the turn of the millennium, the population of the United States clocked in at 282.2 million. By 2030, the US population is expected to be about 362......(read more)
RENAISSANCE TECHNOLOGIES

Renaissance Technologies Bullish on PepsiCo (PEP) and Gold Heading Into Q2

Founded in 1982 by James ‘Jim’ Simons, Renaissance Technologies employs quantitative models based on mathematical and statistical analysis to make......(read more)
RENAISSANCE TECHNOLOGIES

Multi-Billion-Dollar Fund Renaissance Technologies Entered Q4 With These Top Picks

Well-known hedge fund Renaissance Technologies LLC needs little or no introduction at all. Jim Simons, also known as the “Quant King”, founded Renaissance......(read more)
FISHER ASSET MANAGEMENT

Billionaire Ken Fisher’s Top Healthcare Stock Picks

At the beginning of September, when the U.S stock markets were in turmoil, Ken Fisher of Fisher Asset Management asserted that the August correction would......(read more)
10 Pharmacist Shortage Countries in Need of Pharmacists in 2017

New Deal Between Emisphere Technologies Inc. (EMIS) and Novo Nordisk A/S (ADR) (NVO)

On October 15, Emisphere Technologies Inc. (OTCMKTS:EMIS) announced an agreement with Novo Nordisk A/S (ADR) (NYSE:NVO) to develop and market oral formulations......(read more)
RENAISSANCE TECHNOLOGIES

Not Even Jim Simons’ Mathematical Models Could Pick Winning Stocks In Q3

Renaissance Technologies, led by Jim Simons, disclosed a total of 3,196 positions in its latest 13F filing for the reporting period of June 30. The fund......(read more)

This is What Hedge Funds Have to Say about Two Healthcare Stocks on the Move

Novo Nordisk A/S (ADR) (NYSE:NVO) and Sanofi SA (ADR) (NYSE:SNY) are two healthcare companies that recently received product approval in the US and Europe......(read more)
Tom Gayner

UnitedHealth Group (UNH), Novo Nordisk (NVO), Johnson & Johnson (JNJ): Cheapest Healthcare Stocks Picked By Markel Gayner

Tom Gayner’s Markel Gayner Asset Management, the investment division of financial holding company Markel Corporation (NYSE:MKL), has filed its latest......(read more)
Amazon.com (NASDAQ:AMZN), The Washington Post (NYSE:WPO), Berkshire Hathaway Inc. (NYSE:BRK.A), Apple Inc. (NASDAQ:AAPL)

Hedge Funds Made A Bundle By Betting On Amazon.com, Inc. (AMZN), Apple, and Pfizer Inc

As we are entering into the second quarter of 2015, it’s time to take a brief look back and see how the market performed during the first three......(read more)
RENAISSANCE TECHNOLOGIES

Colgate-Palmolive Company (CL), Novo Nordisk A/S (ADR) (NVO) Among Billionaire Jim Simons’ Holdings for Long-Run

The quantitative hedge fund Renaissance Technologies, formerly managed by billionaire Jim Simons, has been so successful that it has been partly responsible......(read more)
RENAISSANCE TECHNOLOGIES

McDonald’s Corporation (MCD), Novo Nordisk A/S (ADR) (NVO), Colgate-Palmolive Company (CL): A Look At Jim Simons’ Top Picks for the Second Quarter

Another major hedge fund that recently disclosed its long equity positions for the second quarter of 2014 is Jim Simons’ Renaissance Technologies, one......(read more)
RENAISSANCE TECHNOLOGIES

Renaissance Technologies Loves These Stocks: McDonald’s Corporation (MCD), Novo Nordisk A/S (ADR) (NVO) & Others

In the latest 13F, Renaissance Technologies, previously managed by Jim Simons, revealed its holding for the fourth quarter of 2013. There was only a slight......(read more)
Novo Nordisk A/S (ADR) (NYSE:NVO)

Is Novo Nordisk A/S (ADR) (NVO) Going to Burn These Hedge Funds?

Should Novo Nordisk A/S (ADR) (NYSE:NVO) investors track the following data? In the 21st century investor’s toolkit, there are a multitude of metrics......(read more)
Allergan, Inc. (NYSE:AGN)

Allergan, Inc. (AGN): Hedge Funds Are Bullish and Insiders Are Undecided, What Should You Do?

Is Allergan, Inc. (NYSE:AGN) a buy? In the eyes of many of your fellow readers, hedge funds are seen as useless, old financial vehicles of an era lost......(read more)
MannKind Corporation (NASDAQ:MNKD)

MannKind Corporation (MNKD), Novo Nordisk A/S (ADR) (NVO), Eli Lilly & Co. (LLY): Dreamboat Data? Not Exactly.

MannKind Corporation (NASDAQ:MNKD) ended up more than 10% on Wednesday, after the biotech announced positive results for two phase 3 trials testing its......(read more)
Novo Nordisk A/S (ADR) (NYSE:NVO)

Novo Nordisk A/S (ADR) (NVO): Insiders Aren’t Crazy About It

Novo Nordisk A/S (ADR) (NYSE:NVO) was in 13 hedge funds’ portfolio at the end of the first quarter of 2013. NVO shareholders have witnessed a decrease......(read more)

Pfizer Inc. (PFE)’s New Model

Pfizer Inc. (NYSE:PFE) is trying a new sales paradigm, selling direct to patients. If this effort works, it could completely change the pharmaceutical......(read more)